In consultation with Consulting Editor, Dr. Samir Taneja, Dr. Sia Daneshmand has put together a state-of the-art issue of the Urologic Clinics devoted to Modern Management of Testicular Cancer. The issue focuses on surgical techniques and diagnostic modalities for testicular cancer. Clinical review articles are specifically devoted to the following: Imaging For Testicular Cancer; Management of Stage I Germ Cell Tumors; Management of Stage II Germ Cell Tumors; Current Management Of Disseminated GCT; Post-Chemotherapy Resection of Residual Mass in NSGCT; Indications For Surgery in Disseminated Seminoma; Growing Teratoma Syndrome; Management of The Primary Testicular Tumor; High-Dose Chemotherapy and Autologous Stem Cell Transplantation; mRna As Biomarkers For Germ Cell Tumors; Minimally Invasive RPLND: Is There a Role?; Complications of RPLND; Preservation of Fertility in Testis Cancer Management. Readers will come away with the latest information they need to optimize surgical and management outcomes in the patient with testicular cancer.
1. Cover image - p. i 2. Title page - p. i 3. Table of Contents - p. i 4. Copyright - p. ii 5. Contributors - p. iii 6. Forthcoming Issues - p. xi 7. Preface - p. xiii 8. The Role of Imaging in the Diagnosis, Staging, Response to Treatment, and Surveillance of Patients with Germ Cell Tumors of the Testis - p. 315 9. Management of Primary Testicular Tumor - p. 333 10. Preservation of Fertility in Testis Cancer Management - p. 341 11. Management of Clinical Stage I Germ Cell Tumors - p. 353 12. Management of Stage II Germ Cell Tumors - p. 363 13. Current Management of Disseminated Germ Cell Tumors - p. 377 14. Postchemotherapy Resection of Residual Mass in Nonseminomatous Germ Cell Tumor - p. 389 15. Indications for Surgery in Disseminated Seminoma - p. 399 16. The Role of Robotic Retroperitoneal Lymph Node Dissection for Testis Cancer - p. 409 17. Management, Treatment, and Molecular Background of the Growing Teratoma Syndrome - p. 419 18. Complications of Retroperitoneal Lymph Node Dissection - p. 429 19. High-Dose Chemotherapy and Autologous Stem Cell Transplant - p. 439 20. MicroRNAs as Biomarkers for Germ Cell Tumors - p. 449
No hay muestra disponible
No hay ficha técnica disponible
In consultation with Consulting Editor, Dr. Samir Taneja, Dr. Sia Daneshmand has put together a state-of the-art issue of the Urologic Clinics devoted to Modern Management of Testicular Cancer. The issue focuses on surgical techniques and diagnostic modalities for testicular cancer. Clinical review articles are specifically devoted to the following: Imaging For Testicular Cancer; Management of Stage I Germ Cell Tumors; Management of Stage II Germ Cell Tumors; Current Management Of Disseminated GCT; Post-Chemotherapy Resection of Residual Mass in NSGCT; Indications For Surgery in Disseminated Seminoma; Growing Teratoma Syndrome; Management of The Primary Testicular Tumor; High-Dose Chemotherapy and Autologous Stem Cell Transplantation; mRna As Biomarkers For Germ Cell Tumors; Minimally Invasive RPLND: Is There a Role?; Complications of RPLND; Preservation of Fertility in Testis Cancer Management. Readers will come away with the latest information they need to optimize surgical and management outcomes in the patient with testicular cancer.
1. Cover image - p. i 2. Title page - p. i 3. Table of Contents - p. i 4. Copyright - p. ii 5. Contributors - p. iii 6. Forthcoming Issues - p. xi 7. Preface - p. xiii 8. The Role of Imaging in the Diagnosis, Staging, Response to Treatment, and Surveillance of Patients with Germ Cell Tumors of the Testis - p. 315 9. Management of Primary Testicular Tumor - p. 333 10. Preservation of Fertility in Testis Cancer Management - p. 341 11. Management of Clinical Stage I Germ Cell Tumors - p. 353 12. Management of Stage II Germ Cell Tumors - p. 363 13. Current Management of Disseminated Germ Cell Tumors - p. 377 14. Postchemotherapy Resection of Residual Mass in Nonseminomatous Germ Cell Tumor - p. 389 15. Indications for Surgery in Disseminated Seminoma - p. 399 16. The Role of Robotic Retroperitoneal Lymph Node Dissection for Testis Cancer - p. 409 17. Management, Treatment, and Molecular Background of the Growing Teratoma Syndrome - p. 419 18. Complications of Retroperitoneal Lymph Node Dissection - p. 429 19. High-Dose Chemotherapy and Autologous Stem Cell Transplant - p. 439 20. MicroRNAs as Biomarkers for Germ Cell Tumors - p. 449
No hay muestra disponible
No hay ficha técnica disponible
